EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-κB Pathway in Mice

He Fang, Xingtong Wang, Mahendra Damarla, Rongju Sun, Qingli He, Ruojing Li, Pengfei Luo, Jun O Liu iD, Zhaofan Xia iD

Mediators of Inflammation · 2023

DOI: 10.1155/2023/5133505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2023. Verfasst von He Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, 168 ChangHai Road, Yangpu District, Shanghai 200433, China. Hauptthemen laut MEDLINE: NF-kappa B, Sepsis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Natural Science Foundation of China, Shanghai Science and Technology Innovation Action Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is one of the most severe complications and causes of mortality in the clinic. It remains a great challenge with no effective treatment for clinicians worldwide. Inhibiting the release of proinflammatory cytokines during sepsis is considered as an important strategy for treating sepsis and improving survival. In the present study, we have observed the effect of dimethyl fumarate (DMF) on lipopolysaccharide- (LPS-) induced sepsis and investigated the possible mechanism. By screening a subset of the Johns Hopkins Drug Library, we identified DMF as a novel inhibitor of nitric oxide synthesis in LPS-stimulated RAW264.7 cells, suggesting that DMF could be a potential drug to treat sepsis. To further characterize the effect of DMF on LPS signaling, TNF-α, MCP-1, G-CMF, and IL-6 expression levels were determined by using cytokine array panels. In addition, an endotoxemia model with C57BL/6 mice was used to assess the in vivo efficacy of DMF on sepsis. The survival rate was assessed, and HE staining was performed to investigate histopathological damage to the organs. DMF was found to increase the survival of septic mice by 50% and attenuate organ damage, consistent with the reduction in IL-10, IL-6, and TNF-α (inflammatory cytokines) in serum. In vitro experiments revealed DMF’s inhibitory effect on the phosphorylation of p65, IκB, and IKK, suggesting that the primary inhibitory effects of DMF can be attributed, at least in part, to the inhibition of phosphorylation of IκBα, IKK as well as nuclear factor-κB (NF-κB) upon LPS stimulation. The findings demonstrate that DMF dramatically inhibits NO and proinflammatory cytokine production in response to LPS and improves survival in septic mice, raising the possibility that DMF has the potential to be repurposed as a new treatment of sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BSepsisMiceAnimalsLipopolysaccharidesDimethyl FumarateTumor Necrosis Factor-alphaInterleukin-6Mice, Inbred C57BLCytokines

Substanzen

NF-kappa BLipopolysaccharidesDimethyl FumarateTumor Necrosis Factor-alphaInterleukin-6Cytokines

Autor:innen und Institutionen

  • Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, 168 ChangHai Road, Yangpu District, Shanghai 200433, China.
  • Department of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, 725 North Wolfe Street, Baltimore, MD 21205, USA.
  • Research Unit of Key Techniques for Treatment of Burns and Combined Burns and Trauma Injury, Chinese Academy of Medical Sciences, 168 ChangHai Road, Yangpu District, Shanghai 200433, China.
  • Department of Burns and Plastic Surgery, The Fourth Medical Center of General Hospital, The People's Liberation Army, Beijing 100048, China.
  • Department of Pulmonary and Critical Care Medicine, The Johns Hopkins Hospital, 1830 E. Monument Street, Baltimore, MD 21287, USA.
  • Department of Emergency, The Eighth Medical Center, General Hospital of PLA, Beijing 100853, China.

ORCID-Profile: Jun O Liu, Zhaofan Xia

Förderung

  • NHLBI NIH HHS
  • National Natural Science Foundation of China
  • Shanghai Science and Technology Innovation Action Plan
  • Chinese Academy of Medical Sciences
  • Military Medical Program of General Hospital
  • Flight Attendant Medical Research Institute
  • Liu Lab
  • National Institutes of Health

Zitieren

APA

Fang, H., Wang, X., Damarla, M., Sun, R., He, Q., Li, R., Luo, P., Liu, J. O., & Xia, Z. (2023). Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-κB Pathway in Mice. Mediators of Inflammation. https://doi.org/10.1155/2023/5133505

Vancouver

Fang H, Wang X, Damarla M, Sun R, He Q, Li R, et al. Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-κB Pathway in Mice. Mediators of Inflammation. 2023. doi:10.1155/2023/5133505

BibTeX
@article{Fang2023,
  author = {Fang, He and Wang, Xingtong and Damarla, Mahendra and Sun, Rongju and He, Qingli and Li, Ruojing and Luo, Pengfei and Liu, Jun O and Xia, Zhaofan},
  title = {Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-κB Pathway in Mice},
  journal = {Mediators of Inflammation},
  year = {2023},
  doi = {10.1155/2023/5133505}
}
Kostenlos starten →